Omada Health director receives 10,882 RSU award

Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Klapstein Julie D reported acquisition or exercise transactions in this Form 4 filing.

Omada Health, Inc. director Julie D. Klapstein received a grant of 10,882 restricted stock units, each representing one share of Common Stock at no purchase price. Following this award, she holds 21,316 shares directly. The RSUs vest 100% on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, subject to continued service.

Insider Trade Summary

Grant/Award: 10,882 shares

Grant/Award 1 txn

Insider Klapstein Julie D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	10,882	$0.00	$0.00

Holdings After Transaction: Common Stock — 21,316 shares (Direct)

Footnotes (1)

1. F1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.

Key Figures

RSU grant size: 10,882 shares Award price: $0.0000 per share Post-transaction holdings: 21,316 shares +1 more

4 metrics

RSU grant size 10,882 shares Restricted stock units awarded to director Julie D. Klapstein

Award price $0.0000 per share Stated transaction price per share for RSU grant

Post-transaction holdings 21,316 shares Total Omada Health Common Stock held directly after grant

Vesting trigger First anniversary or 2027 meeting RSUs vest on earlier of first grant anniversary or 2027 Annual Meeting, subject to service

Key Terms

restricted stock units ("RSUs"), vesting, Annual Meeting of the Issuer's stockholders

3 terms

restricted stock units ("RSUs") financial

"Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vesting financial

"receive one (1) share of Common Stock for each RSU upon vesting."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Annual Meeting of the Issuer's stockholders financial

"the date of the 2027 Annual Meeting of the Issuer's stockholders"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Omada Health (OMDA) disclose for Julie D. Klapstein?

Omada Health reported that director Julie D. Klapstein received a grant of 10,882 restricted stock units. Each RSU represents one share of Common Stock, awarded at no purchase price, increasing her direct holdings to 21,316 shares after the transaction.

How many Omada Health (OMDA) shares did Julie D. Klapstein hold after the RSU grant?

After the grant, Julie D. Klapstein held 21,316 shares of Omada Health Common Stock. This total reflects the addition of 10,882 restricted stock units awarded in the transaction, which each entitle her to one share upon vesting, subject to service conditions.

What are the vesting terms of Julie D. Klapstein’s Omada Health (OMDA) RSUs?

The 10,882 restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of Omada Health stockholders. Vesting is conditioned on Julie D. Klapstein’s continued service through the applicable vesting date.

Did Julie D. Klapstein pay for the Omada Health (OMDA) RSU grant?

No, Julie D. Klapstein did not pay a purchase price for these RSUs. The Form 4 lists the transaction price per share as 0.0000, indicating a compensation-related equity award rather than an open-market purchase of Omada Health Common Stock.

Is Julie D. Klapstein’s Omada Health (OMDA) RSU grant a derivative transaction?

The filing categorizes the RSU grant as a non-derivative acquisition of Common Stock, with details clarified in a footnote. That footnote explains the shares constitute restricted stock units convertible into one share of Common Stock per unit upon vesting, subject to service.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 04:21 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Klapstein Julie D

(Last) (First) (Middle)

C/O OMADA HEALTH, INC.

611 GATEWAY BLVD., SUITE 120

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Omada Health, Inc. [ OMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A		10,882(1)	A	$0	21,316	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 100% of the RSUs will fully vest on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, subject to continued service through such vesting date.

	/s/ Nathan Salha, as Attorney-in-Fact for Julie D. Klapstein	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)